BioPharma Dive2h
FDA lifts pause on Novavax flu vaccine trials
The Food and Drug Administration has cleared Novavax to move forward with testing of a combination vaccine for COVID-19 and ...
Monthly Prescribing Reference3h
Reactogenicity Comparable for Simultaneous, Sequential COVID-19, Flu Shots
The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold — Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
US FDA lifts clinical hold on Novavax's combo COVID-flu shot
The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.
American Lung Association5d
Fact or Fiction: Answers to Your Flu Vaccine FAQs
"With over 50 years of history and hundreds of millions of flu vaccines administered safely in the U.S., the flu shot remains a vital tool in our public health arsenal," said Harold Wimmer, President ...